University of Manitoba
His primary areas of study are Virology, Virus, Immunology, Ebola virus and Vesicular stomatitis virus. His study ties his expertise on Immune system together with the subject of Virology. His work in the fields of Orthomyxoviridae, Influenza A virus subtype H5N1 and Influenza A virus overlaps with other areas such as Respiratory infection.
Many of his research projects under Immunology are closely connected to Coronavirus with Coronavirus, tying the diverse disciplines of science together. His Ebola virus study integrates concerns from other disciplines, such as Ecology and Highly pathogenic. The various areas that he examines in his Ebolavirus study include Transmission, Viremia, Ebola vaccine and Vector.
Steven M. Jones focuses on Virology, Ebola virus, Immunology, Virus and Vesicular stomatitis virus. Steven M. Jones works mostly in the field of Virology, limiting it down to concerns involving Monoclonal antibody and, occasionally, Polyclonal antibodies. His Ebola virus research is multidisciplinary, incorporating elements of Microbiology and Vaccination.
His Virus research includes elements of Interferon and Innate immune system. His Vesicular stomatitis virus research focuses on Vector and how it relates to ZMapp and Viremia. His studies deal with areas such as Secondary infection, Influenza A virus subtype H5N1 and Orthomyxoviridae, Influenza A virus as well as Immunity.
The scientist’s investigation covers issues in Virology, Ebola virus, Zaire ebolavirus, Immunology and Glycoprotein. His research on Virology focuses in particular on Ebola vaccine. In general Ebola virus study, his work on Ebolavirus often relates to the realm of Materials science and Transmission electron microscopy, thereby connecting several areas of interest.
His studies in Zaire ebolavirus integrate themes in fields like Epitope, Antigen, Vesicular stomatitis virus and Innate immune system. As a part of the same scientific study, Steven M. Jones usually deals with the Immunology, concentrating on Knockout mouse and frequently concerns with Virus, Interferon and Crimean Congo hemorrhagic fever virus. His Glycoprotein study combines topics from a wide range of disciplines, such as Ebola virus infection, Antibody, Monoclonal antibody and Time to death.
His main research concerns Virology, Monoclonal antibody, Antibody, Immunofluorescence and Epitope. With his scientific publications, his incorporates both Virology and Proinflammatory cytokine. His Proinflammatory cytokine research spans across into subjects like Knockout mouse, Virus, Immune system, Immunology and Cytokine storm.
He interconnects Interferon, Pathogenesis and Crimean Congo hemorrhagic fever virus in the investigation of issues within Knockout mouse. His work carried out in the field of Monoclonal antibody brings together such families of science as Vesicular stomatitis virus, Zaire ebolavirus, Glycoprotein and Ebola virus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus
Darwyn Kobasa;Steven M. Jones;Steven M. Jones;Kyoko Shinya;John C. Kash.
Properties of Replication-Competent Vesicular Stomatitis Virus Vectors Expressing Glycoproteins of Filoviruses and Arenaviruses
Michael Garbutt;Ryan Liebscher;Victoria Wahl-Jensen;Steven Jones;Steven Jones.
Journal of Virology (2004)
Ebola virus: from discovery to vaccine
Heinz Feldmann;Steven Jones;Hans-Dieter Klenk;Hans-Joachim Schnittler.
Nature Reviews Immunology (2003)
Effective post-exposure treatment of Ebola infection.
Heinz Feldmann;Steven M Jones;Steven M Jones;Kathleen M Daddario-DiCaprio;Kathleen M Daddario-DiCaprio;Joan B Geisbert.
PLOS Pathogens (2007)
Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates.
Thomas W. Geisbert;Kathleen M. Daddario-DiCaprio;Mark G. Lewis;Joan B. Geisbert.
PLOS Pathogens (2008)
Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery.
Tsung Hsien Chang;Toru Kubota;Mayumi Matsuoka;Steven Jones.
PLOS Pathogens (2009)
Human immune response to a plague vaccine comprising recombinant F1 and V antigens.
E. D. Williamson;H. C. Flick-Smith;C. LeButt;C. A. Rowland.
Infection and Immunity (2005)
Severe Acute Respiratory Syndrome-Related Coronavirus Is Inhibited by Interferon-α
Ute Ströher;Antonino DiCaro;Yan Li;James E. Strong.
The Journal of Infectious Diseases (2004)
Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model
Dennis A. Bente;Judie B. Alimonti;Judie B. Alimonti;Wun Ju Shieh;Gaëlle Camus;Gaëlle Camus.
Journal of Virology (2010)
Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses
Thomas W. Geisbert;Kathleen M. Daddario-DiCaprio;Kathleen M. Daddario-DiCaprio;Joan B. Geisbert;Joan B. Geisbert;Douglas S. Reed.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: